Interestingly, Yi et al applied human colorectal carcinoma HCT116 cell line with a near-diploid genome carrying only one UPF3B copy and generated two independent UPF3B KO cell lines with the CRISPR-Cas9 technology (Yi et al, 2022). Here, UPF3B is linked to colorectal carcinoma.